1.
Neurology
; 102(9): e209365, 2024 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38648603
2.
J Extra Corpor Technol
; 46(2): 170-2, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25208436
RESUMO
Heparin-induced thrombocytopenia presents a challenge for anticoagulation techniques during cardiac surgery and ventricular assist device implantation. Bivalirudin is currently recommended for use during cardiopulmonary bypass for patients with heparin-induced thrombocytopenia but requires the use of special techniques to avoid blood stagnation. We report the successful use of bivalirudin during cardiopulmonary bypass for implantation of the Total Artificial Heart with late operative bleeding likely resulting from heavy cell saver use.